T-THERAPEUTICS LIMITED

Active Great Abington
69 employees website.com
Life sciences and medical technology
T

T-THERAPEUTICS LIMITED

Founded 10 May 2022 Active Great Abington, United Kingdom 69 employees website.com
Life sciences and medical technology
Accounts Due 30 Sept 2026 5 months remaining
Confirmation
Net assets £13M £4M 2024 year on year
Total assets £16M £6M 2024 year on year
Total Liabilities £3M £2M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

One Granta Granta Park Great Abington CB21 6DP United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for T-THERAPEUTICS LIMITED (14097070), an active life sciences and medical technology company based in Great Abington, United Kingdom. Incorporated 10 May 2022. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£8.73M

Increased by £3.07M (+54%)

Net Assets

£13.16M

Increased by £3.85M (+41%)

Total Liabilities

£3.32M

Increased by £2.06M (+164%)

Turnover

N/A

Employees

69

Increased by 36 (+109%)

Debt Ratio

20%

Increased by 8 (+67%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (6)

Investor NameInvestor SinceParticipating Rounds
Investor 1Nov 2023Series A
Investor 2Nov 2023Series A
Investor 3Nov 2023Series A

Share Capital

Share Capital

Share allotments and capital structure

13 Allotments 701,337,332 Shares £57.24m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
13 Jan 2026299,382£0.299£0
13 Jan 202653,175£0.005£0.005
22 Oct 2025140,350,001£14.04m£0.1
16 Sept 202516,680£0.005£0.005
16 Sept 202516,680£0.005£0.005

Officers

Officers

3 active
Status
Graziano SeghezziDirectorItalian,frenchFrance5715 Nov 2022Active
Rajah, Luke ElliottDirectorBritishEngland3822 Oct 2025Active
Robert Giles TansleyDirectorBritishEngland6215 Nov 2022Active

Shareholders

Shareholders (16)

Sofinnova Capital X
29.6%
109,336,105
F-prime Capital Partners Life Sciences Fund Vii Lp
19.1%
70,539,424

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased

Allan Bradley

Ceased 14 May 2025

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
One Granta, Granta Park, Great Abington, Cambridge (CB21 6DP) SOUTH CAMBRIDGESHIRE
Leasehold-18 Sept 2024
One Granta, Granta Park, Great Abington, Cambridge (CB21 6DP)
Leasehold
Added 18 Sept 2024
District SOUTH CAMBRIDGESHIRE

Documents

Company Filings

DateCategoryDescriptionDocument
16 Apr 2026CapitalAllotment of shares (GBP 752.82593) on 2026-03-31
16 Feb 2026CapitalAllotment of shares (GBP 752.749226) on 2026-01-13
9 Dec 2025OfficersAppointment of Viet-Anh Anne Horgan as director on 2025-12-01
8 Dec 2025OfficersTermination of David Hung as director on 2025-11-30
8 Dec 2025OfficersTermination of Robert Giles Tansley as director on 2025-12-01
16 Apr 2026 Capital

Allotment of shares (GBP 752.82593) on 2026-03-31

16 Feb 2026 Capital

Allotment of shares (GBP 752.749226) on 2026-01-13

9 Dec 2025 Officers

Appointment of Viet-Anh Anne Horgan as director on 2025-12-01

8 Dec 2025 Officers

Termination of David Hung as director on 2025-11-30

8 Dec 2025 Officers

Termination of Robert Giles Tansley as director on 2025-12-01

Recent Activity

Latest Activity

Allotment of shares (GBP 752.82593) on 2026-03-31

3 days ago on 16 Apr 2026

Allotment of shares (GBP 752.749226) on 2026-01-13

2 months ago on 16 Feb 2026

Appointment of Viet-Anh Anne Horgan as director on 2025-12-01

4 months ago on 9 Dec 2025

Termination of David Hung as director on 2025-11-30

4 months ago on 8 Dec 2025

Termination of Robert Giles Tansley as director on 2025-12-01

4 months ago on 8 Dec 2025